Britannia Life Sciences IncCanadian Securities Exchange:BLABView on OTC Pink - Current Information
- LAST PRICE0.0400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0400/ 41
- Ask / Lots0.0500/ 50
- Open / Previous Close0.0400 / 0.0400
- Day Range
- 52 Week Range
- Volume2,000
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BLAB |
|---|---|---|
| 02:00 ET | 1000 | 0.04 |
| 04:00 ET | 1000 | 0.04 |
Oct 10, 2024
Britannia Launches Financing to Support Britannia Mining Solutions Lab Rollout, from 8:03PM ET on Thursday Oct 10, 2024 by Dow Jones
8:03PM ET on Thursday Oct 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Britannia Life Sciences Inc | 6.5M | -1.2x | --- |
Else Nutrition Holdings Inc | 6.3M | -0.3x | --- |
Emergence Global Enterprises Inc | 5.0M | -7.6x | --- |
Good Shroom Co Inc | 5.3M | -214.3x | --- |
Relevium Technologies Inc | 6.8M | -1.3x | --- |
Blender Bites Ltd | 8.7M | -1.5x | --- |
Company Information
Britannia Life Sciences Inc. is a Canada-based vertically diversified product development, quality assurance and safety and regulatory compliance company. The Company is focused on introducing cutting-edge technologies into the traditional laboratory and regulatory platforms to power data-driven insights to improve the outcomes of its customers. The Company provides product testing, safety assessment and compliance services to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally. Its services, including product formulations, safety assessments, analytical and microbiological testing, global compliance, and consumer evaluations are offered to companies. It also provides geochemical testing and analysis to the natural resources industry through its subsidiary Britannia Mining Solutions. Britannia Mining Solutions operates a geochemical laboratory in the United States and is in the process of rolling out 12 PhotonAssay machines globally.
Contact Information
- Headquarters
- 120 Adelaide Street West; Suite 2400TORONTO, ON, Canada M5H 1T1
- Phone
- 416-930-7711
- Fax
- 416-302-0779
Executives
- Independent Chairman of the Board
- Greg Taylor
- Chief Executive Officer, Director
- Peter Shippen
- Chief Financial Officer, Company Secretary
- Sarah Zilik
- Chief Technology Officer
- Mark Bowes-cavanagh
- Independent Director
- Scott Secord
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.5M |
|---|---|
Revenue (TTM) | $7.4M |
Shares Outstanding | 162.3M |
Britannia Life Sciences Inc does not pay a dividend. | |
Beta | 3.78 |
EPS | $-0.03 |
Book Value | $0.02 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | 0.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -68.76% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
